NMPA Approval

Compound Paracetamol and Amantadine Hydrochloride Tablets

Approval Number

国药准字H14023974

Company山西丕康药业有限公司

Registration Date

April 20, 2020

Drug Information

Generic Name

复方氨酚烷胺片

Dosage Form

片剂

Strength

复方

Drug Type

化学药品

Registration Date

April 20, 2020

Company Information

Applicant Company

Company Name山西丕康药业有限公司

Manufacturing Company

Company Name山西丕康药业有限公司

Company Address

山西省绛县经济开发区（卫庄镇增村）

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

复方氨酚烷胺片 - NMPA 批准文号 | MedPath